Pulsed Field Therapy, Pulsed Electromagnetic Resonance Therapy in The Treatment of Childhood Asthma. Clinical Trial 761100036
Phase 2
Recruiting
- Conditions
- Childhood and infant asthma.Respiratory - Asthma
- Registration Number
- ACTRN12607000361404
- Lead Sponsor
- Biological Control Systems Pty Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Children, infants and babies. Trial participants must have been diagnosed with asthma and have been treated for at least 3 months prior to enrolment.
Exclusion Criteria
Do not satisfy the inclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage reduction in asthma as measured using a rating scale based on number of day and night symptoms of asthma[Measured at 12 weeks, 24 weeks, 36 weeks and 52 weeks after intervention commencement.];Number and type of medications required to treat asthma[Measured at 12 weeks, 24 weeks, 36 weeks and 52 weeks after intervention commencement.];Peak flow[Measured at 12 weeks, 24 weeks, 36 weeks and 52 weeks after intervention commencement.]
- Secondary Outcome Measures
Name Time Method If children are asthma free at 36 weeks then intervention will be ceased and at 52 weeks trial participants will be tested for asthma to determine if this is a total cure ie no interventional therapy is required to be free of asthma. [];Overall health will be measured using a computer generated and a interactive rating scale considering over 180 indicators of health being a mixture of items starting at A” for allergies and ending at W” for wound healing.[]